『GEN Podcasts』のカバーアート

GEN Podcasts

GEN Podcasts

著者： Genetic Engineering & Biotechnology News (GEN)
無料で聴く

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

Genetic Engineering & Biotechnology News (GEN) has retained its position as the premier biotech publication since its launch in 1981. GEN publishes a print edition monthly and has additional exclusive editorial content online, including news and analysis as well as webinars, videos, and polls. GEN's unique news and technology focus covers the entire bioproduct life cycle, including drug discovery, early-stage R&D, applied research (e.g., omics, biomarkers, and diagnostics), bioprocessing, and commercialization.

GEN's print magazine, which also can easily be accessed online, includes feature articles on emerging technologies, product roundups, in-depth overviews from key scientific and bioindustry meetings, and industry-standard tutorials and technical articles on drug discovery, bioprocessing, and assay technologies.

Hosted on Acast. See acast.com/privacy for more information.

Genetic Engineering & Biotechnology News (GEN) 生物科学 科学
エピソード
  • Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.

    Enabling In Vivo Lentiviral Therapies: Manufacturing Strategies to Improve Purity, Scalability, and Clinical Readiness.
    2026/04/21

    Lentiviral vectors are gaining momentum not just as ex vivo tools but as potential in vivo therapeutic platforms. But with that shift comes a number of manufacturing challenges, including higher doses, tighter control of impurities, greater batch consistency, and scalable processes to meet both clinical and commercial needs.


    In this GEN Podcast, two experts from SK Pharmteco, a global CMO, address these challenges and lay out some best practices that guide the manufacture of lentiviral vectors with the requisite purity, robustness, and economic feasibility required for widespread clinical adoption.


    Guest speakers:

    Mardhani Aparajithan, Director of Manufacturing, Science and Technology, SK Pharmteco


    Tatiana Nanda, PhD, CTO, Cell and Gene Therapy, SK Pharmteco


    Moderator:

    Kevin Davies, PhD, Editorial Director, GEN

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    35 分
  • The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera

    The Future of Bioinformatics: Scaling Interactive and Computational Workflows with Seqera
    2025/04/11

    Sponsored by Seqera


    As data volumes in life sciences continue to grow, bioinformaticians and researchers are more dependent than ever on solutions that help them streamline workflows, manage data, and scale their research. In this timely podcast, Evan Floden, CEO and co-founder of Seqera, shares how his company is addressing these needs through Nextflow—the open-source orchestrator for scalable, reproducible, and portable scientific workflows—and Seqera Platform, a unified solution for the entire scientific data lifecycle. He also discusses how Seqera has become a widely adopted solution, trusted by 13 of the top 20 pharmaceutical companies, empowering breakthroughs in drug discovery, genomics, clinical research, and.beyond.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    18 分
  • Smart Vector Design for Improved Cell and Gene Therapies

    Smart Vector Design for Improved Cell and Gene Therapies
    2025/04/08
    In the episode, we’re talking about vector design and delivery for gene therapies. The field of cell and gene therapies is advancing, but there are still challenges with delivery vectors that need to be addressed. In this podcast, experts discuss current immunogenicity hurdles, evolving DMPK strategies, and a new generation of bioanalytical tools that are contributing to the progress in the field.

    Hosted on Acast. See acast.com/privacy for more information.
    続きを読む 一部表示
    1 時間 1 分
adbl_web_anon_alc_button_suppression_c
まだレビューはありません